Добавил:
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Книги по МРТ КТ на английском языке / MRI for Orthopaedic Surgeons Khanna ed 2010

.pdf
Скачиваний:
18
Добавлен:
05.10.2023
Размер:
35.56 Mб
Скачать

420 V Special Considerations

Fig. 17.6 Three-phase bone scan: to evaluate for osteomyelitis. In this 30-year-old female with a history of diabetes mellitus, left fifth metatarsal injury, overlying ulcer, and infection with clinical suspicion of osteomyelitis, conventional radiographs of the foot were negative for osteomyelitis or fracture. (A) The anterior blood flow image of the distal lower extremity shows asymmetrically increased blood flow to the entire left foot (arrow) with more focally increased

blood flow to the left fifth digit (arrowheads). (B) A blood pool image shows increased blood pool di usely in the left foot and more focally in the left fifth digit (arrows). (C) The delayed bone phase image shows focal, increased tracer uptake in the left fifth proximal and distal phalanx (arrows). Both sites are three-phase positive on bone scan, consistent with osteomyelitis. (Courtesy of Heather Jacene, MD.)

17 Correlation of MRI with Other Imaging Studies 421

specificity: MRI is exquisitely sensitive to the presence of bone marrow edema and can show associated soft-tissue involvement. MRI is considered the imaging modality of choice for the early detection of osteomyelitis. Nuclear scintigraphy has an advantage in that it can quickly reveal other areas of involvement, which is a particularly important advantage for the pediatric patient who may have multiple sites of infec-

tion.17 It is important to note that when bone turnover is exceptionally high, such as in a patient with multiple myeloma and other lytic processes, conventional bone scan techniques may result in false-negative findings.18,19

Nuclear scintigraphy can also be used to help determine the age or physiologic activity of vertebral compression and other fractures20–22 (Fig. 17.7). In such cases, nuclear

A–C

 

Fig. 17.7 Three-phase bone scan: to evaluate age and activity of vertebral compres-

 

sion fractures. Lateral (A) and posteroanterior (B) radiographs of an elderly woman with

 

osteoporosis showing L2 and L3 vertebral compression fractures. (C) A sagittal recon-

 

structed CT image better shows the osseous detail and configuration of the fractures,

 

but it does not allow for accurate assessment of the relative age or physiologic activity

 

of the fracture. (D) A posteroanterior delayed bone-phase image from a three-phase

D

bone scan shows intense radiotracer uptake within the L2 and L3 vertebral bodies, sug-

gestive of an acute or subacute fracture that is physiologically active.

422 V Special Considerations

scintigraphy may be indicated in patients for whom MRI is

nant lesions.23–26 In one study of 45 heterogeneous lesions,

contraindicated, such as those with claustrophobia or non–

positron emission scanning provided high sensitivity and

MRI-compatible pacemakers and defibrillators.

specificity for the di erentiation of malignant and benign le-

 

 

sions (91% and 100%, respectively24), but positron emission

 

 

tomography remains to be validated with larger studies.

Positron Emission Tomography

Novel applications of positron emission tomography

 

 

 

 

continue to be developed. Preliminary studies have shown

As does nuclear scintigraphy, positron emission tomography

that it can e ectively determine whether vertebral com-

facilitates the evaluation of the physiologic activity in the tis-

pression fractures are pathologic in nature or secondary to

sues, in this case, glucose metabolism. Specifically, the patient is

osteoporosis alone.27,28 Recent work has shown a potential

injected with a marker, 18-F-labeled 2-fluoro-2-deoxyglucose,

role for positron emission tomography in patients with

which emits gamma rays based on the rate of glucose metabo-

arthroplasty in terms of evaluating osteolysis and deter-

lism. A limited number of centers throughout North America

mining whether the prosthetic loosening is aseptic or in-

provide this imaging modality, and therefore access to positron

fectious in nature.29–31 The combined technique of positron

emission scanning may be somewhat di cult to obtain.

emission tomography and CT has recently been advocated

The most common indication for positron emission scan-

for use in diagnostically di cult cases of adolescent back

ning is for the evaluation of malignant metastases or tumor

pain.32 The strength of this technique lies in the combina-

recurrence (Fig. 17.8); positron emission tomography has

tion and correlation of functional data with the detailed

shown limited promise in di erentiating benign and malig-

anatomic findings of CT.

Fig. 17.8 A 50-year-old male with bladder transitional cell carcinoma. A proton emission tomography/CT image shows foci of intense fluorodeoxyglucose activity fusing a lumbar vertebra and pedicle, the sternum, and a right rib (arrows). Despite the lack of abnormality

on the corresponding CT image, these findings are most consistent with bony metastases. PET, positron emission tomography. (Courtesy of Heather Jacene, MD.)

 

 

17 Correlation of MRI with Other Imaging Studies 423

 

 

 

 

 

 

tained with conventional radiographs and MRI. However,

Summary

for selected patients, the clinician must make the deci-

For the appropriate evaluation of a patient with muscu-

sion to request other imaging studies, such as CT, nuclear

loskeletal disease, it is important for clinicians to use all

scintigraphy, and positron emission tomography, as they

of the imaging tools and modalities in their armamen-

are indicated. With time, one can expect improvements

tarium. E cacy, cost, availability, and patient limitations

in technology and the development of new imaging mo-

all play roles in imaging modality selection. In most cases,

dalities that can be integrated into diagnosis and treatment

most of the clinically important information can be ob-

algorithms.

References

17.

Santiago Restrepo C, Giménez CR, McCarthy K. Imaging of osteomy-

 

 

 

elitis and musculoskeletal soft tissue infections: current concepts.

1.

Steinbach HL. The roentgen appearance of osteoporosis. Radiol Clin

 

Rheum Dis Clin North Am 2003;29:89–109

 

North Am 1964;2:191–207

18.

Ghanem N, Lohrmann C, Engelhardt M, et al. Whole-body MRI in

2.

Kamholtz R, Sze G. Current imaging in spinal metastatic disease.

 

the detection of bone marrow infiltration in patients with plasma

 

Semin Oncol 1991;18:158–169

 

cell neoplasms in comparison to the radiological skeletal survey. Eur

3.

Fayad LM, Johnson P, Fishman EK. Multidetector CT of musculo-

 

Radiol 2006;16:1005–1014

 

skeletal disease in the pediatric patient: principles, techniques, and

19.

Mulligan ME. Myeloma update. Semin Musculoskelet Radiol

 

clinical applications. Radiographics 2005;25:603–618

 

2007;11:231–239

4.

Fayad LM, Bluemke DA, Fishman EK. Musculoskeletal imaging with

20.

Masala S, Schillaci O, Massari F, et al. MRI and bone scan imag-

 

computed tomography and magnetic resonance imaging: when is

 

ing in the preoperative evaluation of painful vertebral fractures

 

computed tomography the study of choice? Curr Probl Diagn Radiol

 

treated with vertebroplasty and kyphoplasty. In Vivo 2005;19:

 

2005;34:220–237

 

1055–1060

5.

Genant HK, Wilson JS, Bovill EG, Brunelle FO, Murray WR, Rodrigo JJ.

21.

Maynard AS, Jensen ME, Schweickert PA, Marx WF, Short JG, Kallmes

 

Computed tomography of the musculoskeletal system. J Bone Joint

 

DF. Value of bone scan imaging in predicting pain relief from percu-

 

Surg Am 1980;62:1088–1101

 

taneous vertebroplasty in osteoporotic vertebral fractures. AJNR Am

6.

Wilson JS, Korobkin M, Genant HK, Bovill EG Jr. Computed tomo-

 

J Neuroradiol 2000;21:1807–1812

 

graphy of musculoskeletal disorders. AJR Am J Roentgenol

22.

Fernandez-Ulloa M, Klostermeier TT, Lancaster KT. Orthopaedic

 

1978;131:55–61

 

nuclear medicine: the pelvis and hip. Semin Nucl Med 1998;28:25–

7.

Geijer M, El-Khoury GY. MDCT in the evaluation of skeletal trauma:

 

40

 

principles, protocols, and clinical applications. Emerg Radiol

23.

Bastiaannet E, Groen H, Jager PL, et al. The value of FDG-PET in the

 

2006;13:7–18

 

detection, grading and response to therapy of soft tissue and bone

8.

Newton PO, Hahn GW, Fricka KB, Wenger DR. Utility of three-

 

sarcomas; a systematic review and meta-analysis. Cancer Treat Rev

 

dimensional and multiplanar reformatted computed tomography

 

2004;30:83–101

 

for evaluation of pediatric congenital spine abnormalities. Spine

24.

Feldman F, van Heertum R, Manos C. 18FDG PET scanning of benign

 

(Phila Pa 1976) 2002;27:844–850

 

and malignant musculoskeletal lesions. Skeletal Radiol 2003;32:

9.

Mui LW, Engelsohn E, Umans H. Comparison of CT and MRI in pa-

 

201–208

 

tients with tibial plateau fracture: can CT findings predict ligament

25.

Lodge MA, Lucas JD, Marsden PK, Cronin BF, O’Doherty MJ, Smith

 

tear or meniscal injury? Skeletal Radiol 2007;36:145–151

 

MA. A PET study of 18FDG uptake in soft tissue masses. Eur J Nucl

10.

Lee E, Worsley DF. Role of radionuclide imaging in the orthopedic

 

Med 1999;26:22–30

 

patient. Orthop Clin North Am 2006;37:485–501

26.

Schwarzbach MHM, Dimitrakopoulou-Strauss A, Willeke F, et al.

11.

McCarthy EF, Frassica FJ. Diagnosing bone disease. In: McCarthy EF,

 

Clinical value of [18-F] fluorodeoxyglucose positron emission

 

Frassica FJ, eds. Pathology of Bone and Joint Disorders: With Clinical

 

tomography imaging in soft tissue sarcomas. Ann Surg 2000;231:

 

and Radiographic Correlation. Philadelphia: WB Saunders; 1998:1–24

 

380–386

12.

Abdel-Dayem HM. The role of nuclear medicine in primary bone and

27.

Schmitz A, Risse JH, Textor J, et al. FDG-PET findings of vertebral

 

soft tissue tumors. Semin Nucl Med 1997;27:355–363

 

compression fractures in osteoporosis: preliminary results. Osteo-

13.

Deutsch AL, Coel MN, Mink JH. Imaging of stress injuries to bone.

 

poros Int 2002;13:755–761

 

Radiography, scintigraphy, and MR imaging. Clin Sports Med

28.

Shin DS, Shon OJ, Byun SJ, Choi JH, Chun KA, Cho IH. Di erentia-

 

1997;16:275–290

 

tion between malignant and benign pathologic fractures with F-18-

14.

Greenspan A, Stadalnik RC. A musculoskeletal radiologist’s view of

 

fluoro-2-deoxy-D-glucose positron emission tomography/computed

 

nuclear medicine. Semin Nucl Med 1997;27:372–385

 

tomography. Skeletal Radiol 2008;37:415–421

15.

Alazraki NP. Radionuclide imaging in the evaluation of infections

29.

Delank KS, Schmidt M, Michael JWP, Dietlein M, Schicha H, Eysel

 

and inflammatory disease. Radiol Clin North Am 1993;31:783–794

 

P. The implications of 18F-FDG PET for the diagnosis of endopros-

16.

El-Maghraby TAF, Moustafa HM, Pauwels EKJ. Nuclear medicine

 

thetic loosening and infection in hip and knee arthroplasty: re-

 

methods for evaluation of skeletal infection among other diagnostic

 

sults from a prospective, blinded study. BMC Musculoskelet Disord

 

modalities. Q J Nucl Med Mol Imaging 2006;50:167–192

 

2006;7:20–28

424 V Special Considerations

30.Manthey N, Reinhard P, Moog F, Knesewitsch P, Hahn K, Tatsch K. The use of [18 F] fluorodeoxyglucose positron emission tomography to di erentiate between synovitis, loosening and infection of hip and knee prostheses. Nucl Med Commun 2002;23:645–653

31.Mumme T, Reinartz P, Alfer J, Müller-Rath R, Buell U, Wirtz DC. Diagnostic values of positron emission tomography versus triple-phase

bone scan in hip arthroplasty loosening. Arch Orthop Trauma Surg 2005;125:322–329

32.Ovadia D, Metser U, Lievshitz G, Yaniv M, Wientroub S, Even-Sapir E. Back pain in adolescents: assessment with integrated 18F-fluoride positron-emission tomography-computed tomography. J Pediatr Orthop 2007;27:90–93

18 MRI Safety

Monica D. Watkins and Bruce A. Wasserman

As with any procedure, maintaining the safety of the patient and health care team during an MRI examination is of utmost importance, and patient safety considerations begin with the referring clinician. A sound understanding of MRI safety issues not only ensures minimal risk to the patient but also can avoid needless expenses and delays in examinations. Although the MRI center is generally responsible for safety screening, the referring physician can minimize even further the chance of an adverse e ect by being aware of important contraindications to MRI and of safety concerns that might put an individual at risk. It can be very comforting to a patient to have the clinician alleviate safety concerns and answer preliminary questions that might otherwise contribute to a growing anxiety in the days leading up to the examination. This chapter reviews these issues and provides guidelines for maximizing safety.

Physiologic E ects of the Magnetic Field

In an MRI scanner, the patient’s body is subjected to the baseline static magnetic field and the time-varying magnetic fields created by RF fields and receiver coils. The strength of these magnetic fields is measured in gauss or tesla (T) units; 1 T equals 10,000 gauss. For comparison, the strength of the earth’s magnetic field is 0.6 gauss; the strength of clinical MRI scanners generally ranges from 0.5 to 3.0 T.1 The FDA has guidelines for the exposure of patients to both static and time-varying magnetic fields.2

a nonspecific wave form) secondary to the conductive nature of blood have been noted.6 However, this “magnetohydrodynamic e ect” has not been associated with a clinically adverse e ect.

At strengths of 4 T, patients may experience transient reversible biologic e ects, such as nausea (that may be caused by stimulation of the vestibulolabryrinthine complex) or a flashing light sensation (magnetophosphenes, thought to be caused by direct excitation of the optic nerves or retina, by changing magnetic fields, or by rapid eye movements).7

Time-Varying Magnetic Fields

Time-varying magnetic fields or gradient magnetic fields can induce current in the body, which can have two possible biologic e ects: heating and neuromuscular stimulation. Even in the absence of metal implants, body temperatures have been shown to rise during MRI, although temperature changes were minor (i.e., <0.6°C).8 The FDA has suggested guidelines to limit the risk of these e ects by restricting the strength of time-varying magnetic fields.2 The intensity of the RF energy absorbed by tissue is termed the specific absorption rate and is measured in watts per kilogram. The FDA reports that specific absorption rates of ≤3 W/kg for the head, ≤4 W/kg (averaged) for the rest of the body, and ≤8.0 W/kg for any 1 g of tissue pose no substantial risk.2 Usually, higher specific absorption rate exposures are a concern with faster pulse sequences.

Static Magnetic Fields

Currently, the FDA approves clinical imaging using a static magnetic field strength of up to 4.0 T for patients <1 month old and up to 8.0 T for older patients.2 Many studies have evaluated the potential biologic e ects of a static magnetic field, and there has been no clear evidence of deleterious effects.3 Although there have been concerns about an elevation of skin and core body temperatures induced by the magnetic field, investigators have concluded that harmful heating does not occur in human subjects.4,5 Reversible electrocardiogram changes (e.g., an increase in the amplitude of the T wave or

Metallic Substances

Field Distortion

Image quality depends on the ability to maintain homogeneity of the magnetic field surrounding the patient. Metallic artifacts can result in misregistered spatial information or signal loss, leading to image distortion. Three types of magnetic materials may cause artifacts because of their inherent abilities to disturb the uniformity of magnetic fields used for imaging: ferromagnetic, paramagnetic, and diamagnetic materials. Of these three, ferromagnetic materials

425

426

V Special Considerations

 

 

(e.g., iron, nickel, and martensitic stainless steel) concentrate

Implant Safety Profiles

 

and retain magnetism the most, resulting in severe distor-

The FDA requires testing of all implants to evaluate their

 

tion of the images. Paramagnetic or weakly ferromagnetic

 

safety profiles and classify them as MRI safe, condition-

 

materials (e.g., platinum) have a minimal e ect on mag-

 

ally safe, or unsafe. The list of these devices is extensive

 

netic field homogeneity and result in less image distortion.

 

and constantly changing, especially as more objects are

 

Diamagnetic materials (e.g., zinc, gold, and copper) do not

 

tested at 3 T and higher, precluding a complete review of

 

a ect or a ect only minimally the static or local magnetic

 

these devices in this chapter. A regularly updated list of re-

 

fields.

 

viewed implants and devices is available online at http://

 

 

 

Metallic Objects in Magnetic Fields

www.MRIsafety.com. It is important to be aware of devices

 

that absolutely contraindicate MRI scanning, including the

 

The clinical value of an MRI examination in a patient with

following:

 

 

 

metallic hardware depends on the proximity of the hard-

• Implantable cardiac defibrillators

 

ware to the site of interest. For example, one can anticipate a

 

• Cardiac pacemakers

 

limited evaluation of neural foramina adjacent to an anterior

 

• Implantable medication infusion pumps

 

cervical fusion or an inability to detect an epidural abscess

 

• Ferromagnetic aneurysm clips (e.g., stainless steel)

 

adjacent to pedicle screw instrumentation. Newer pulse se-

 

• Poppen-Blaylock carotid artery clamps

 

quences have been developed that allow for imaging in the

 

• Spinal/bone fusion stimulators

 

presence of metallic implants (see Chapter 16). Myelography

 

• Cochlear implants

 

remains a viable alternative for the postoperative spine. CT

 

• Tissue expanders

 

also is a valuable alternative in postoperative patients, par-

 

• Gastric electrical stimulation devices

 

ticularly in conjunction with myelography.

 

 

 

In addition to causing distortion of images, some metal-

Certain models of some devices (e.g., implantable cardiac

 

lic foreign bodies or surgical implants can move or gener-

defibrillators, cardiac pacemakers, spinal/bone fusion

 

ate heat in the presence of a magnetic field, possibly leading

stimulators, and cochlear implants) may be scanned under

 

to injury or death.9,10 For this reason, each patient must be

strict criteria. However, many MRI centers still consider as

 

screened for metallic objects within the body, usually with a

absolute contraindications the presence of such devices or

 

verbal interview and a written checklist.

of devices that do not meet the required technical condi-

 

Of particular concern are metallic foreign bodies within

tions (see below). Of note, the Starr-Edwards Model Pre-

 

the orbit that may dislodge and rupture the globe or dam-

6000 heart valve prosthesis (Baxter Healthcare, Santa Ana,

 

age the optic nerve. To our knowledge, there is only one re-

CA) is now designated as conditionally MRI safe, although

 

ported case of a patient who su ered a vitreous hemorrhage,

previously it was thought to be an absolute contraindication

 

caused by a dislodged metal fragment (2.0 × 3.5 mm), that

to an MRI examination.13 In recent years, multiple in vitro

 

led to blindness.11 Although it is standard for MRI facilities to

and in vivo controlled studies have shown increasing evi-

 

prescreen for metallic orbital foreign bodies, methods of ac-

dence that some patients with cardiac pacemakers can be

 

complishing this screening vary. Conventional radiographs

scanned safely under specific conditions, despite the poten-

 

of the orbits are said to detect metallic fragments as small as

tial for arrhythmia and death.14–18 However, in most situa-

 

0.1 × 0.1 × 0.1 mm. However, there is debate over which pa-

tions, a pacemaker remains an absolute contraindication for

 

tients should be referred for conventional radiographs. Many

MRI unless the procedure is an orchestrated e ort between

 

MRI centers obtain orbital radiographs of patients with an

cardiology and radiology, with informed consent of the

 

occupational history of welding, but some experts advocate

patient.19,20

 

obtaining films only if the patient is aware of a previous or-

Similar caution is warranted for patients with neurostim-

 

bital exposure to metal without removal of the fragment by

ulation systems for deep brain stimulation of the thalamus,

 

an ophthalmologist.12 At the authors’ institution, patients

globus pallidus, and subthalamic nucleus as a treatment for

 

with a history of working with metal undergo screening

movement disorders. Although many patients have been

 

orbital conventional radiographs. Alternatively, review of a

scanned successfully without incident, there are specific

 

previous CT scan, including the entirety of the orbits, is often

guidelines regarding the technique.21,22 Currently, the Pul-

 

considered su cient.

sar Cochlear Implant (MED-EL Corp., Durham, NC) can be

 

In addition to assessing for orbital foreign bodies, the cli-

scanned, but only under specific conditions on a 0.2-T ma-

 

nician should question the patient regarding any history of

chine. The Nucleus 24 Auditory Brainstem Implant System

 

metallic foreign bodies near other vital structures, such as

(Cochlear Corp., Englewood, CO) has a removable magnet

 

the lungs or spinal cord. For example, bullet fragments in the

and may be scanned up to 1.5 T, again under specific condi-

 

spinal canal contraindicate MRI because they may be ferro-

tions. It is suggested that the manufacturer of these cochlear

 

magnetic.

devices be contacted before imaging.23 In general, imaging of

18 MRI Safety 427

deep-brain stimulators and this specific implant should be

Superficial Metal

performed only after discussion with a neurologist and radi-

There are safety concerns not only with internal metallic

ologist. There are six specific requirements that also must be

devices but also with skin surface metal, such as medicine

met to obtain an MRI study of a patient with a spinal/bone

patches containing a metal foil, surgical staples, tattoos,

fusion stimulator24,25:

• Cathodes of the implantable spinal fusion stimulator

or permanent cosmetics. It is standard practice to remove

transdermal medicine patches containing metallic foil at the

should be a minimum of 1 cm from nerve roots.

time of an MRI. Tope and Shellock31 reviewed the results of a

• Conventional radiographs should be obtained before

questionnaire given to 1032 patients with cosmetic tattoos.

MRI to verify that there are no broken leads for the im-

Only two patients experienced any sensory consequences

plantable spinal fusion stimulator.

(i.e., “slight tingling” or a “burning” sensation). These sen-

• The study should be obtained on an MRI system

sations are thought to be caused by heating from iron ox-

with static fields of 1.5 T or less, avoiding pulse se-

ide or other metal-based pigment. The FDA Center for Food

quences that expose patient to high levels of RF

Safety and Applied Nutrition, O ce of Cosmetics and Colors

energy.

fact sheet states, “The risks of avoiding an MRI when your

• The patient should be observed continuously.

doctor has recommended one are likely to be much greater

• To reduce artifact, the implantable spinal fusion stim-

than the risk of complications from the interaction between

ulator should be placed as far from the spinal canal and

the MRI and tattoo or permanent makeup.”32 Most prac-

bone graft as possible.

tices agree that an ice pack or cold compress can be applied

• Selected imaging techniques, such as the use of FSE

during scanning to the site of the tattoo, permanent cos-

pulse sequences, should be used to reduce artifact.

metics, or surgical staples to reduce the chance of thermal

In the past, residual pacing wires also were considered to be

injury.

 

a contraindication to MRI. However, the current consensus

 

is that such patients may undergo MRI if the wires are cut

External Metallic Objects

short (flush with skin) and there are no loops of wire outside

In addition to precautions about internal foreign bodies, MRI

the patient. Again, consultation with the patient’s cardiolo-

gist may be necessary.26

centers screen for external metallic devices that may become

Devices that are conditionally safe for MRI are implants

projectiles in the MRI suite. Injuries and death have occurred

that may be scanned if certain guidelines are satisfied.

when large metallic objects, such as a ferrous oxygen tank,

These devices include weakly magnetic intravascular fil-

have been brought into the MRI suite.33–35 Even small objects

ters, stents, and coils. MRI of patients with such devices

that may not seem dangerous to many patients, such as jew-

may require a waiting period of 6 to 8 weeks after implan-

elry or hairpins, can become projectiles and cause injury. It

tation to ensure that movement of the device caused by the

is standard procedure to ask patients to remove such objects

magnetic field does not disturb its implantation onto the

and to empty their pockets.

vessel wall.27,28 The evolving list of all such devices is be-

 

yond the scope of this chapter, but in general, one should

 

acquire additional information (e.g., brand name of the de-

Pregnancy

 

vice and date of implantation) for patients who have under-

 

gone recent placement of such devices. Many MRI centers

Although there are no known deleterious e ects of an MRI

require documentation of this information before scanning

examination during pregnancy, concerns about potential

is allowed.

side e ects remain. One such concern is that electromag-

Devices that are safe for MRI are those known to produce

netic fields could disrupt cell division. Because cell division

no clinically significant hazard in the MRI environment. In

is more rapid in the first trimester, it usually is acceptable to

general, these devices have no electronically or magnetically

delay MRI until after the first trimester.

activated component, are made from a nonferromagnetic

Because of such potential complications, MRI during

material (such as titanium or nitinol), and may undergo

pregnancy is obtained on a case-by-case basis, weighing

MRI scanning at ≤1.5 T immediately after implantation.29,30

the risk and benefit for each examination; this procedure

Many of these devices have been tested in the 3-T environ-

is the accepted standard of care advocated by the American

ment. It is important to obtain the brand name of the device

College of Radiology.36 Shellock and Kanal37 have suggested

from patients (who may have the package insert) or from

that “MR imaging may be used in pregnant women if other

their records. Safe devices also include orthopaedic implants

nonionizing forms of diagnostic imaging are inadequate or if

firmly placed within the bone because, although they may

the examination provides important information that would

be weakly magnetic, they do not dislodge or generate sub-

otherwise require exposure to ionizing radiation.” In almost

stantial heat.

all institutions, written, informed consent is obtained.

428

 

V Special Considerations

 

 

 

 

 

alysis within 2 days of gadolinium administration. The tim-

 

 

Contrast

 

 

ing of dialysis relative to gadolinium administration may be

 

 

MRI contrast agents are often used in the postoperative pa-

critical for the prevention of this disease, but thus far little

 

 

tient to evaluate for infection or scar tissue, in patients with

is known regarding the e ectiveness of dialysis in reducing

 

 

known or suspected musculoskeletal tumors, and for MR

the risk of nephrogenic systemic fibrosis.43 At the authors’

 

 

angiography of the carotid and peripheral arteries. The gad-

institution, a creatinine/estimated glomerular filtration rate

 

 

olinium ion contains seven unpaired electrons in the outer

measurement is currently obtained for patients at risk for

 

 

shell, providing a large magnetic moment. This paramag-

renal dysfunction, including those ≥65 years old or with a

 

 

netic property enhances the relaxation rates of nearby water

history of diabetes, those with renal disease or transplanta-

 

 

protons. Although gadolinium itself is toxic, chelation with

tion, and those with liver disease or hepatorenal syndrome.

 

 

other substances makes it nontoxic and usable as a contrast

In pregnant patients, contrast agents cross the placenta,

 

 

agent. Over time, within the body, the free gadolinium ion

enter the fetal collecting system, and then are excreted into

 

 

can dissociate from its chelate. Normally, the amount of free

the amniotic fluid. To the authors’ knowledge, no studies

 

 

ions is low because of rapid clearance through the kidney.

show the clearance rate of MRI contrast agents in the fetus,

 

 

In addition to screening for the specific populations listed

but it is possible that a chelated gadolinium agent could stay

 

below, it is important to obtain a patient’s allergy history,

within the amniotic fluid long enough to allow toxic free

 

especially with regard to whether the patient had a reaction

ions to accumulate. Gadolinium-based intravenous MR con-

 

to gadolinium contrast previously and, if so, the nature of

trast is labeled by the FDA as a category C medication; that

 

that reaction. A history of a mild reaction (such as hives) to

is, there is a lack of controlled studies with which to evaluate

 

gadolinium generally requires premedication with predni-

the e ects. Contrast is generally not administered to preg-

 

sone and diphenhydramine. A history of reactions as severe

nant patients unless the potential benefit outweighs its risks

 

as respiratory or circulatory compromise is a contraindica-

and unless written, informed consent has been obtained.20,44

 

tion to the use of MRI contrast. An adverse reaction to MRI

The theoretic risk of free ion accumulation is smaller if the

 

contrast is rare and generally expected to occur in less than

agent is administered toward the end of gestation in the

 

1% of patients.38 Reactions range from headache to weakness

third trimester, leaving less time for dissociation and accu-

 

and, very rarely, anaphylaxis.38

mulation of free ions before fetus delivery.

 

 

For patients with renal failure, there is concern that de-

When a breast-feeding mother receives contrast, it is

 

 

creased renal clearance may result in accumulating free ion

expected that most of the contrast will have cleared by 24

 

 

levels and toxicity. Clinicians usually recommend that a

hours, leaving minimal residual contrast (<0.04%) to be ex-

 

 

patient undergo dialysis within 24 hours after contrast ad-

creted into the breast milk.20,45 However, a breast-feeding

 

 

ministration. The FDA recently issued an alert for the use of

woman should be given the option to abstain from breast-

 

 

gadolinium intravenous contrast in patients with advanced

feeding for 24 hours and to pump and discard breast milk for

 

 

renal failure (i.e., those currently requiring dialysis or with an

this time period.

 

 

estimated glomerular filtration rate of <30 mL/min/1.73m2)

Other patient populations have a theoretic risk of toxic-

 

 

because of the risk of inducing nephrogenic systemic fibrosis/

ity from gadolinium, although no direct clinical evidence has

 

 

nephrogenic fibrosing dermopathy.39

been established. For example, patients with elevated levels

 

 

Nephrogenic systemic fibrosis/nephrogenic fibrosing der-

of copper (such as those with Wilson disease) or zinc may

 

 

mopathy is a progressive and sometimes fatal disease seen in

have increased free ion accumulation after contrast adminis-

 

 

patients with reduced renal function, and it causes fibrosis of

tration because these metals may compete with gadolinium

 

 

the skin and connective tissues throughout the body, includ-

for the chelate. In vivo studies suggest that gadolinium ad-

 

 

ing muscles of the extremities or abdomen, the diaphragm,

ministration can lead to vasoocclusive complications in pa-

 

 

and pulmonary vessels. Gadolinium has been detected in the

tients with sickle cell disease because deoxygenated sickle

 

 

soft tissues of several patients with nephrogenic systemic

erythrocytes align perpendicularly to a magnetic field.46,47

 

 

fibrosis who were exposed to it as a radiographic contrast

However, no clinical evidence suggests that these agents

 

 

agent, supporting its association with this disease.40 Deo et

precipitate a sickle cell crisis. Some facilities consider sickle

 

al41 studied a population of end-stage renal disease patients

cell disease to be a contraindication to the administration of

 

 

for 18 months and found that each radiologic study that used

gadolinium.

 

 

a gadolinium-based contrast agent presented a 2.4% risk for

Physicians, both clinicians and radiologists, are often

 

 

nephrogenic systemic fibrosis. Broome et al42 reported an

faced with the decision to give gadolinium contrast to a pa-

 

 

odds ratio of 22.3 (95% confidence interval; range, 1.3 to

tient with a history of an allergy to ionic contrast agents,

 

 

378.9) for the development of nephrogenic systemic fibrosis

such as those used for CT. Studies have shown that patients

 

 

after gadolinium exposure in 168 dialysis patients. An impor-

with a history of an ionic contrast allergy are at a higher risk

 

 

tant observation in that study was that 10 of the 12 patients

for a reaction, as are those with asthma and multiple medi-

 

 

who developed nephrogenic systemic fibrosis underwent di-

cation allergies.38,48 Often, MRI centers will require consent

18 MRI Safety 429

from such patients before giving contrast, and some centers may require that the patient be premedicated.

alternative. However, image quality may be sacrificed in this procedure because of the lower field strength of some open MRI systems.

Claustrophobia

The key to obtaining an informative MRI study is a cooperative patient who is able to remain still for the duration of the examination. Scanning an uncooperative patient often leads to poor image quality with motion artifact, and it increases the anxiety level of the individual for future examinations. It is important to identify claustrophobic patients who may be unable to tolerate the examination and to determine if sedation is needed. In some cases, patients’ fears and anxiety may be alleviated by being told they can communicate with the technicians via an intercom and can stop the examination if needed. A benzodiazepine, such as diazepam, may be used to sedate a nervous patient, with additional monitoring provided by the nursing sta . Occasionally, a patient may be unable to tolerate imaging, even with sedation. In such cases, an open (unenclosed) MRI examination might be the best

References

1.Roth CK. Patient care and safety for magnetic resonance imaging. In: Rad Tech’s Guide to MRI: Imaging Procedures, Patient Care, and Safety. Williston, VT: Blackwell Science Publishers; 2002:1–38

2.United States Department of Health and Human Services. Criteria for Significant Risk Investigations of Magnetic Resonance Diagnostic Devices. Rockville, MD: U.S. Department of Health and Human Services, O ce of the Surgeon General; 2003

3.Schenck JF. Health e ects and safety of static magnetic fields. In: Shellock FG, ed. Magnetic Resonance Procedures: Health E ects and Safety. Boca Raton, FL: CRC Press; 2001:1–29

4.Shellock FG, Schaefer DJ, Crues JV. Exposure to a 1.5-T static magnetic field does not alter body and skin temperatures in man. Magn Reson Med 1989;11:371–375

5.Shellock FG, Schaefer DJ, Gordon CJ. E ect of a 1.5 T static magnetic field on body temperature of man. Magn Reson Med 1986;3:644– 647

6.Chakeres DW, Kangarlu A, Boudoulas H, Young DC. E ect of static magnetic field exposure of up to 8 Tesla on sequential human vital sign measurements. J Magn Reson Imaging 2003;18:346–352

7.Schenck JF, Dumoulin CL, Redington RW, Kressel HY, Elliott RT, McDougall IL. Human exposure to 4.0-Tesla magnetic fields in a wholebody scanner. Med Phys 1992;19:1089–1098

8.Shellock FG, Crues JV. MR procedures: biologic e ects, safety, and patient care. Radiology 2004;232:635–652

9.Boutin RD, Briggs JE, Williamson MR. Injuries associated with MR

imaging: survey of safety records and methods used to screen patients for metallic foreign bodies before imaging. AJR Am J Roentgenol 1994;162:189–194

10.Klucznik RP, Carrier DA, Pyka R, Haid RW. Placement of a ferromagnetic intracerebral aneurysm clip in a magnetic field with a fatal outcome. Radiology 1993;187:855–856

Summary

Although MRI facilities are mandated to present patients with a prescreening checklist, the referring physician can prevent the need to reschedule the patient or abort the procedure by beginning the screening process and alleviating some of the concerns or fears the patient may have regarding the examination. It is imperative that the physician be familiar with the few absolute contraindications to MRI and identify patients for whom additional information is needed. Furthermore, brief questions to screen for claustrophobia, pregnancy, and known gadolinium contrast allergy, combined with identifying potential safety hazards via knowledge of the patient’s history that might put the patient at risk during an examination, can facilitate obtaining the most informative and the safest study possible.

11.Kelly WM, Paglen PG, Pearson JA, San Diego AG, Soloman MA. Ferromagnetism of intraocular foreign body causes unilateral blindness after MR study. AJNR Am J Neuroradiol 1986;7:243–245

12.Seidenwurm DJ, McDonnell CH III, Raghavan N, Breslau J. Cost utility analysis of radiographic screening for an orbital foreign body before MR imaging. AJNR Am J Neuroradiol 2000;21:426–433

13.Shellock FG. Heart valve prostheses and annuloplasty rings. In: Reference Manual for Magnetic Resonance Safety, Implants, and Devices: 2007 Edition. Los Angeles: Biomedical Research Publishing Group; 2007:224–226

14.Gimbel JR, Johnson D, Levine PA, Wilko BL. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol 1996;19:913–919

15.Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004;43:1315–1324

16.Pennell DJ. Cardiac magnetic resonance with a pacemaker in-situ: can it be done? J Cardiovasc Magn Reson 1999;1:72

17.Roguin A, Zviman MM, Meininger GR, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation 2004;110:475–482

18.Sommer T, Vahlhaus C, Lauck G, et al. MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology 2000;215:869–879

19.Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005;28:326–328

20.Kanal E, Borgstede JP, Barkovich AJ, et al. American College of Radiology white paper on MR safety. AJR Am J Roentgenol 2002;178: 1335–1347